Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-14 | HCA Healthcare, Inc. | Whalen Kathleen M
(SVP & Chief Ethics Officer) |
S | Common Stock | D | 1474 | $357.99 - $357.99 | $527,677 |
| 2024-11-14 | HCA Healthcare, Inc. | Foster Jon M
(EVP and COO) |
M | Common Stock | A | 36600 | $101.16 - $101.16 | $3,702,456 |
| 2024-11-14 | HCA Healthcare, Inc. | Foster Jon M
(EVP and COO) |
J | Common Stock | D | 19004 | $352.74 - $352.74 | $6,703,470 |
| 2024-05-15 | HCA Healthcare, Inc. | Foster Jon M
(EVP and COO) |
G | Common Stock | D | 50610 | $0.00 - $0.00 | $0 |
| 2024-11-14 | HCA Healthcare, Inc. | Foster Jon M
(EVP and COO) |
F | Common Stock | D | 20902 | $345.51 - $345.51 | $7,221,850 |
| 2024-11-14 | HCA Healthcare, Inc. | Billington Phillip G
(SVP-Internal Audit Services) |
S | Common Stock | D | 3897 | $350.00 - $350.00 | $1,363,950 |
| 2024-11-12 | HCA Healthcare, Inc. | Billington Phillip G
(SVP-Internal Audit Services) |
M | Common Stock | A | 8000 | $68.96 - $68.96 | $551,680 |
| 2024-11-12 | HCA Healthcare, Inc. | Billington Phillip G
(SVP-Internal Audit Services) |
F | Common Stock | D | 4103 | $350.53 - $350.53 | $1,438,224 |
| 2024-11-14 | HCA Healthcare, Inc. | Akdamar Erol R
(Group President) |
S | Common Stock | D | 2900 | $353.00 - $353.00 | $1,023,700 |
| 2024-11-12 | HCA Healthcare, Inc. | Akdamar Erol R
(Group President) |
M | Common Stock | A | 20000 | $68.96 - $68.96 | $1,379,199 |
| 2024-11-12 | HCA Healthcare, Inc. | Akdamar Erol R
(Group President) |
F | Common Stock | D | 10257 | $350.53 - $350.53 | $3,595,386 |
| 2024-11-11 | HCA Healthcare, Inc. | Whalen Kathleen M
(SVP & Chief Ethics Officer) |
M | Common Stock | A | 4710 | $173.12 - $173.12 | $815,395 |
| 2024-11-11 | HCA Healthcare, Inc. | Whalen Kathleen M
(SVP & Chief Ethics Officer) |
F | Common Stock | D | 3236 | $357.99 - $357.99 | $1,158,455 |
| 2024-10-30 | HCA Healthcare, Inc. | Elcan Patricia F
(AtLeastTenPercentOwner) |
J | Common Stock, par value $0.01 per share | D | 2042398 | $361.55 - $361.55 | $738,429,718 |
| 2024-09-12 | HCA Healthcare, Inc. | Cuffe Michael S.
(EVP and Chief Clinical Officer) |
S | Common Stock | D | 8358 | $385.42 - $385.42 | $3,221,340 |
| 2024-09-10 | HCA Healthcare, Inc. | Cuffe Michael S.
(EVP and Chief Clinical Officer) |
M | Common Stock | A | 22080 | $145.24 - $145.24 | $3,206,899 |
| 2024-09-10 | HCA Healthcare, Inc. | Cuffe Michael S.
(EVP and Chief Clinical Officer) |
F | Common Stock | D | 13722 | $386.43 - $386.43 | $5,302,592 |
| 2024-08-06 | HCA Healthcare, Inc. | HAZEN SAMUEL N
(CEO) |
G | Common Stock | D | 58652 | $0.00 - $0.00 | $0 |
| 2024-08-05 | HCA Healthcare, Inc. | Sowell Joseph A III
(SVP; Chief Development Officer) |
G | Common Stock | D | 26734 | $0.00 - $0.00 | $0 |
| 2024-07-29 | HCA Healthcare, Inc. | Whalen Kathleen M
(SVP & Chief Ethics Officer) |
S | Common Stock | D | 4851 | $359.92 - $363.51 | $1,756,694 |
| 2024-07-29 | HCA Healthcare, Inc. | Whalen Kathleen M
(SVP & Chief Ethics Officer) |
M | Common Stock | A | 8280 | $145.24 - $145.24 | $1,202,587 |
| 2024-07-29 | HCA Healthcare, Inc. | Whalen Kathleen M
(SVP & Chief Ethics Officer) |
F | Common Stock | D | 5293 | $358.73 - $358.73 | $1,898,757 |
| 2024-07-29 | HCA Healthcare, Inc. | Reiner Deborah M
(SVP - Mktg. & Communications) |
S | Common Stock | D | 3314 | $359.96 - $359.96 | $1,192,914 |
| 2024-07-29 | HCA Healthcare, Inc. | Wyatt Christopher F.
(SVP & Controller) |
S | Common Stock | D | 4000 | $360.20 - $360.20 | $1,440,782 |
| 2024-07-25 | HCA Healthcare, Inc. | Wyatt Christopher F.
(SVP & Controller) |
M | Common Stock | A | 9300 | $101.16 - $101.16 | $940,788 |
| 2024-07-25 | HCA Healthcare, Inc. | Wyatt Christopher F.
(SVP & Controller) |
F | Common Stock | D | 5278 | $352.79 - $352.79 | $1,862,025 |
| 2024-07-25 | HCA Healthcare, Inc. | Torres Kathryn A.
(SVP-Payer Contracting & Align.) |
S | Common Stock | D | 1857 | $355.05 - $355.05 | $659,327 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |